Good clinical practice and the conduct of clinical studies in pediatric oncology

被引:10
作者
Devine, Susan [2 ]
Dagher, Ramzi N. [3 ]
Weiss, Karen D. [3 ]
Santana, Victor M. [1 ]
机构
[1] St Jude Childrens Hosp, Dept Oncol, Memphis, TN 38105 USA
[2] Hosp Sick Children, Dept Hematol Oncol, Toronto, ON M5G 1X8, Canada
[3] US FDA, Ctr Drug Evaluat & Res, Off Oncol Drug Prod, Silver Spring, MD 20903 USA
关键词
D O I
10.1016/j.pcl.2007.10.008
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
This article discusses the principles that guide good clinical practice standards, with particular emphasis on how they to relate to pediatric oncology research and recent efforts at harmonization. The authors review the clinical trials process and the roles of the participants, highlighting the pivotal role of the clinical investigator and the research team, and briefly review the historical aspects of drug development regulations in the United States and the current regulatory paths for pediatric oncology drug development. Where relevant, historical events that underlie many of the regulations and their current applications are described, and practical examples are provided.
引用
收藏
页码:187 / +
页数:25
相关论文
共 25 条
  • [1] Peer-reviewed publication of clinical trials completed for pediatric exclusivity
    Benjamin, Daniel K., Jr.
    Smith, Philip Brian
    Murphy, M. Dianne
    Roberts, Rosemary
    Mathis, Lisa
    Avant, Debbie
    Califf, Robert M.
    Li, Jennifer S.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (10): : 1266 - 1273
  • [2] Diagnosis of the small round blue cell tumors using multiplex polymerase chain reaction
    Chen, Qing-Rong
    Vansant, Gordon
    Oades, Kahuku
    Pickering, Maria
    Wei, Jun S.
    Song, Young K.
    Monforte, Joseph
    Khan, Javed
    [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2007, 9 (01) : 80 - 88
  • [3] DAGHER R, 2004, ANTICANCER DRUG DEV
  • [4] DAGHER RN, 2007, ANTIANGIOGENIC CANC
  • [5] *EUR MED AG, 2007, MED CHILDR
  • [6] Regulatory approvals of pediatric oncology drugs: Previous experience and new initiatives
    Hirschfeld, S
    Ho, PTC
    Smith, M
    Pazdur, R
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (06) : 1066 - 1073
  • [7] Response to paclitaxel, topotecan, and topotecan cyclophosphamide in children with untreated disseminated neuroblastoma treated in an upfront phase II investigational window: A Pediatric Oncology Group study
    Kretschmar, CS
    Kletzel, M
    Murray, K
    Thorner, P
    Joshi, V
    Marcus, R
    Smith, EI
    London, WB
    Castleberry, R
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (20) : 4119 - 4126
  • [8] LANSKY SB, 1987, CANCER, V60, P1651, DOI 10.1002/1097-0142(19871001)60:7<1651::AID-CNCR2820600738>3.0.CO
  • [9] 2-J
  • [10] Pediatric phase I trials in oncology: An analysis of study conduct efficiency
    Lee, DP
    Skolnik, JM
    Adamson, PC
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (33) : 8431 - 8441